Ramifications of four concurrent thrombophilic mutations and one hypofibrinolytic mutation

Biochemistry, Genetics and Molecular Biology

• Proband 100%
• Gene Mutation 50%
• Anticoagulation 50%
• Homozygosity 50%
• Prothrombin 50%
• Plasminogen Activator Inhibitor-1 50%
• Methylenetetrahydrofolate Reductase 50%
• Factor V Leiden 50%
• Prothrombin G20210A 50%
• Platelet Glycoprotein IIb/IIIa 50%
• Heterozygosity 25%
• Factor VIII 25%
• Plasminogen Activator 25%
• Platelet Glycoprotein 25%
• Compound Heterozygosity 25%
• Deep Vein Thrombosis 25%

Keyphrases

• Thrombophilic mutation 100%
• Leiden 75%
• G1691A 50%
• G20210A 25%
• Plasminogen Activator inhibitor-1 Gene 25%
• Platelet Glycoprotein IIIa 25%
• Thrombophilic 25%
• Prothrombin G20210A mutation 25%
• Prothrombin Gene 25%
• PAI-1 Gene 25%